摘要
干细胞由于其巨大的研究和应用潜力而成为全球关注焦点。许多国家的政府、研究机构和企业对其加大投入,并取得了巨大的进展。与干细胞相关的论文和专利数量在2001年后均快速增加,其临床和临床前研究的数量也越来越多,但目前仍以脐血干细胞项目为主。美国在干细胞研究领域的各个方面均处于世界顶级地位。中国与干细胞相关的论文和专利数量也居世界前十位,但没有一家机构居世界先进行列,也缺乏新产品研发。面对美国相关政策的放宽所带来的格局变化,中国应该积极应对。
Stem cell has become the global focus for its promising potential in research and practice.The governments,Institutes and enterprises all over the world have been increasing investment,and have made great progresses.Stem cell related papers and patents have sharply going up since 2001,and researches on clinic and pre-clinic trials became more and more though majority still focus on umbilical cord blood stem cells.USA remains the top position in all aspects in stem cell field.The numbers of stem cell related papers and patents produced by China are ranking top 10 around the world,but no Institute belongs to top one,and not many new products are developed successfully.China has to learn how to actively react to the changes resulted from related looser policy in USA.
出处
《中国生物工程杂志》
CAS
CSCD
北大核心
2011年第9期132-139,共8页
China Biotechnology
关键词
干细胞
研究
开发
市场
Stem cell Research Development Market